Journal Article

DKFZ-2017-05238

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Peripheral neuropathy associated with subcutaneous or intravenous bortezomib in patients with newly diagnosed myeloma treated within the GMMG MM5 phase III trial.

Merz, M. (First author)DKFZ* ; Salwender, H. ; Haenel, M. ; Mai, E. K. ; Bertsch, U. ; Kunz, C.DKFZ* ; Hielscher, T.DKFZ* ; Blau, I. W. ; Scheid, C. ; Hose, D. ; Seckinger, A. ; Jauch, A. ; Hillengass, J.DKFZ* ; Raab, M.-S.DKFZ* ; Schurich, B. ; Munder, M. ; Brossart, P. ; Gerecke, C. ; Lindemann, H.-W. ; Zeis, M. ; Weisel, K. ; Duerig, J. ; Goldschmidt, H.

2016
Ferrata Storti Foundation Pavia

This record in other databases:  

Please use a persistent id in citations: doi:10.3324/haematol.2016.151266

---

Contributing Institute(s):

1. Radiologie (E010)
2. Biostatistik (C060)
3. KKE Molekulare Hämatologie/Onkologie (G330)

Research Program(s):

1. 315 - Imaging and radiooncology (POF3-315) (POF3-315)

Appears in the scientific report 2016

---

Database coverage:
; ; ; BIOSIS Previews ; Current Contents - Clinical Medicine ; Current Contents - Life Sciences ; DOAJ Seal ; NCBI Molecular Biology Database ; SCOPUS ; Science Citation Index ; Science Citation Index Expanded ; Thomson Reuters Master Journal List ; Web of Science Core Collection

---